According to Aerovate Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ2.21. In 2023 the company made an earnings per share (EPS) of -ยฃ2.14 a decrease over its 2022 EPS that were of -ยฃ1.57.